The Clinical Operations and Development team at Cytocom is responsible for overseeing the planning, execution, and management of clinical trials for the company’s novel immune therapies. This team collaborates closely with regulatory affairs and medical experts to ensure compliance with guidelines while driving projects forward, from trial design to data analysis. Their efforts are crucial in advancing Cytocom’s innovative treatments for Crohn’s Disease, Fibromyalgia, MS, and Pancreatic Cancer toward successful market entry.